看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Bausch Health Companies Inc. |
| HLS Therapeutics Inc. |
| Teva Pharmaceutical Industries Limited |
| Novartis AG |
| Hypera S.A. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| BHC | HLS | TEVA N | NVS | HYPE3 | KHTR.F | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 4% | -23% | -25% | 26% | 11% | 1% | ||
| Fiscal Year - 1 | 69% | -25% | -7% | 16% | 15% | -2% | ||
| Fiscal Year - 2 | 56% | -16% | -27% | 10% | 17% | -4% | ||
| Fiscal Year - 3 | -442% | -8% | 4% | 37% | 17% | 2% | ||
| Fiscal Year - 4 | -70% | -9% | -33% | 14% | 15% | 5% | ||
| Fiscal Year - 5 | -94% | -12% | -7% | 11% | 14% | 2% | ||
| Average | -79% | -15% | -16% | 19% | 15% | 1% | ||
| Median | -33% | -14% | -16% | 15% | 15% | 1% | ||
| Benchmarks | Ticker | |||||||
| Bausch Health Companies Inc. | TSX:BHC | |||||||
| HLS Therapeutics Inc. | TSX:HLS | |||||||
| Teva Pharmaceutical Industries Limited | BMV:TEVAN | |||||||
| Novartis AG | NEOE:NVS | |||||||
| Hypera S.A. | BOVESPA:HYPE3 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | BHC | HLS | TEVA N | NVS | HYPE3 | KHTR.F | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 9,625 | 57 | 16,544 | 51,722 | 7,442 | 371 | ||
| Fiscal Year | 9,625 | 57 | 16,544 | 51,722 | 7,442 | 371 | ||
| Fiscal Year - 1 | 8,757 | 63 | 15,846 | 46,660 | 7,915 | 328 | ||
| Fiscal Year - 2 | 8,124 | 61 | 14,925 | 43,461 | 7,546 | 294 | ||
| Fiscal Year - 3 | 8,434 | 60 | 15,878 | 43,974 | 5,937 | 243 | ||
| Fiscal Year - 4 | 8,027 | 56 | 16,659 | 49,898 | 4,089 | 200 | ||
| Fiscal Year - 5 | 8,601 | 54 | 16,887 | 48,677 | 3,295 | 47 | ||
| Net Income | ||||||||
| Latest Twelve Months | (46) | (20) | (1,639) | 11,941 | 1,333 | 4 | ||
| Fiscal Year | (46) | (20) | (1,639) | 11,941 | 1,333 | 4 | ||
| Fiscal Year - 1 | (592) | (28) | (559) | 8,568 | 1,649 | (17) | ||
| Fiscal Year - 2 | (225) | (24) | (2,446) | 6,049 | 1,705 | (30) | ||
| Fiscal Year - 3 | (948) | (13) | 417 | 22,908 | 1,618 | 16 | ||
| Fiscal Year - 4 | (560) | (15) | (3,990) | 8,072 | 1,322 | 42 | ||
| Fiscal Year - 5 | (1,788) | (20) | (999) | 7,142 | 1,189 | 15 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 27,350 | 209 | 43,479 | 99,945 | 24,509 | 945 | ||
| Latest Fiscal Quarter | 26,523 | 160 | 39,326 | 102,246 | 24,559 | 964 | ||
| Fiscal Year | 26,523 | 160 | 39,326 | 102,246 | 24,559 | 964 | ||
| Fiscal Year - 1 | 27,350 | 209 | 43,479 | 99,945 | 24,509 | 945 | ||
| Fiscal Year - 2 | 25,686 | 242 | 44,011 | 117,453 | 23,756 | 1,055 | ||
| Fiscal Year - 3 | 29,202 | 276 | 47,666 | 131,795 | 19,818 | 992 | ||
| Fiscal Year - 4 | 31,199 | 304 | 50,640 | 127,778 | 17,250 | 1,040 | ||
| Fiscal Year - 5 | 33,863 | 320 | 57,470 | 118,370 | 11,919 | 1,305 | ||
| Fiscal Year - 6 | 32,492 | 306 | 60,683 | 145,563 | 10,557 | 1,052 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | (1,022) | 98 | 7,506 | 46,667 | 11,504 | 747 | ||
| Latest Fiscal Quarter | (1,279) | 71 | 5,373 | 44,046 | 12,096 | 795 | ||
| Fiscal Year | (1,279) | 71 | 5,373 | 44,046 | 12,096 | 795 | ||
| Fiscal Year - 1 | (1,022) | 98 | 7,506 | 46,667 | 11,504 | 747 | ||
| Fiscal Year - 2 | (692) | 125 | 7,804 | 59,342 | 10,646 | 826 | ||
| Fiscal Year - 3 | (106) | 161 | 10,278 | 67,655 | 9,827 | 842 | ||
| Fiscal Year - 4 | 535 | 169 | 10,026 | 56,598 | 9,241 | 886 | ||
| Fiscal Year - 5 | 1,063 | 178 | 13,972 | 55,474 | 8,710 | 811 | ||
| Fiscal Year - 6 | 2,733 | 158 | 14,707 | 78,614 | 8,268 | 1,030 | ||